Document text
Principal Investigator: STEVEN A BENNER
Organization: FOUNDATION FOR APPLIED MOLECULAR EVOLUTN
Fiscal Year: 2023
Award: $671,088
Funding agency: National Institute of Allergy and Infectious Diseases
Basic Research to Diagnostics and Surveillance in Lower Resource Environments
Foundation for Applied Molecular Evolution
Steven A. Benner
ABSTRACT
We will deliver to the NIAID and CDC communities, through basic research, a scientific understanding of
pairing, mispairing, and enzymology of natural DNA and RNA (collectively xNA) that goes deeper than the
axiom that "A pairs with T, and G pairs with C". The experiments are designed to learn:
(a) Why robust multiplexed PCR (mPCR) for clinical use seems impossible with more than 20-30 targets.
(b) Why conventional expedients (including careful primer and probe design, internal nesting, and external
tagging) fail to robustly support multiplexing beyond ~30 targets.
(c) Why those failures are not reproducible from sample to sample.
(d) Why conventional multiplexes targeting n targets often collapse when an n+1th target is added. This
prevents, when a new pathogen emerges (as for 2019-nCoV), a diagnostics maker from simply adding a new
target to an existing mPCR kit, thereby meeting the emergency need.
(e) Why manufacturing specs become increasingly more demanding as the level of multiplexing increases.
These problems restrain 21st century diagnostics to two 20th century design and regulatory paradigms.
(i) A "guess-then-test" paradigm for singleplexed molecular diagnosis, which requires physician to guess
which pathogen might be associated with patient malaise, prescribe a ~$150 singleplexed test based on that
guess, and re-prescribe further tests until a guess proves correct.
(ii) The "inflexible-multiplexed-panel" paradigm. Here, assays are bundled into a multiplex appropriate for a
specific sample and symptom set; failure (d) prevents that multiplex from changing for emerging diseases.
By developing the science of both natural and unnatural DNA (including artificially expanded genetic
information systems, AEGIS, and self avoiding molecular recognition systems, SAMRS), this project will deliver
to researchers, manufacturers, and the FDA science to meet the 21st century NIAID mission. We will:
Task 1. Complete thermodynamic and enzyme rules to place SAMRS optimally in primers that target both DNA
and RNA. Rules will be metricked by comparing predictions made with these rules to experiments.
Task 2. Metric, by deep sequencing, mPCR failures (a) through (e).
Task 3. Metric how AEGIS and SAMRS mitigate or eliminate failures (a) through (e).
Task 4. Identify failure modes that arise with RNA targets specifically. Since RNA has folding options not
available to DNA, these modes may be especially resistant to nucleic acid innovations.
Task 5. Build a body of statistical knowledge for AEGIS-SAMRS mPCR, especially with respect to "add-ons",
quantitative amplification, and manufacturing tolerances. This will help move away from "guess-then-
test" and "inflexible-multiplexed-panel" paradigms, lowing cost, supporting FDA regulatory processes,
and better managing pandemics.
1
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Animals><Assay><Basic Research><Basic Science><Bioassay><Biologic Assays><Biological Assay><Businesses><COVID detection><COVID-19 virus><COVID19 virus><Cessation of life><Chemistry><Clinical><CoV-2><CoV2><Communities><Computer software><DNA><Data><Data Systems><Death><Democracy><Demography><Deoxyribonucleic Acid><Diagnostic><Diagnostic Reagent Kits><Diagnostics Research><Disease><Disorder><Dropout><Drops><Emergencies><Emergency Situation><Enzymatic Biochemistry><Enzyme Gene><Enzymes><Enzymology><Epidemic><Experimental Designs><Failure><Foundations><Future><Guidelines><Health Insurance for Aged and Disabled, Title 18><Health Insurance for Disabled Title 18><Human><IT Systems><Information Systems><Information Technology Systems><Investigators><Knowledge><Learning><Low-resource area><Low-resource community><Low-resource environment><Low-resource region><Low-resource setting><Malaise><Manufacturer><Medicare><Mission><Modern Man><Molecular Diagnosis><Molecular Evolution><NIAID><National Institute of Allergy and Infectious Disease><Non-Polyadenylated RNA><Nucleic Acids><Oral><Paper><Pathogen detection><Patients><Physicians><Process><RNA><RNA Gene Products><Rectum><Regulation><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resistance><Resource-constrained area><Resource-constrained community><Resource-constrained environment><Resource-constrained region><Resource-constrained setting><Resource-limited area><Resource-limited community><Resource-limited environment><Resource-limited region><Resource-limited setting><Resource-poor area><Resource-poor community><Resource-poor environment><Resource-poor region><Resource-poor setting><Resources><Ribonucleic Acid><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Science><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Software><Specific qualifier value><Specified><Speed><Symptoms><System><Temperature><Testing><Thermodynamic><Thermodynamics><Time><Title 18><Travel><Vagina><Vaginal><Writing><Wuhan coronavirus><care costs><coronavirus detection><coronavirus disease 2019 virus><coronavirus disease detection><coronavirus disease-19 virus><cost><deep sequencing><design><designing><detect COVID><detect coronavirus><detect coronavirus disease><diagnostic kit><economic impact><emerging pathogen><experiment><experimental research><experimental study><experiments><flexibility><flexible><genetic information><hCoV19><health insurance for disabled><improved><innovate><innovation><innovative><manufacture><meeting><meetings><melting><molecular recognition><nCoV2><new pathogen><new technology><novel pathogen><novel technologies><pandemic><pandemic disease><pathogen><prevent><preventing><rectal><relative cost><relative costs><resistant><response><restraint><statistics><test kit>